Search academic texts

Information × Registration Number 0304U004959, 0104U009977 , R & D reports Title Clinical study "Evaluation of the efficacy and tolerability of cephaperazon-Darnitsa pulver p/in 1,0 by zao FF Darnitsa production in trial of acute pyelonephritis and exacerbation of chronic pyelonephritis popup.stage_title Клінічне дослідження "Вивчення ефективності і переносимості препарату Цефаперазон-Дарниця порошок д/ін по 1,0 виробництва ЗАТ ФФ Дарниця у пацієнтів на гострий пієлонефріт та хронічний пієлонефрит в фазі загострення Head Svintsitskiy A.S., Registration Date 14-12-2004 Organization National Medical University popup.description2 It was carried out the study of the Cephaperason-Darnitsa pulver for injection 1,0 intreatment of acute and chronic pyelonephritis in comparison to Cephobid by "Pfizer", Germany. The main group consisted of 30 pts, the control one - of 30 pts. The efficacy of Cephtriaxon-Darnitsa was proved in 87 % of cases comparable to control group/ No evidence of side-effects was noticed and tolerability Cephtriaxon-Darnitsa in revealed to be high. Pulver for injection Cephtriaxon-Darnitsa may be used in clinical practice5635 Product Description popup.authors popup.nrat_date 2020-04-02 Close